Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WL Ross & Co. is a private equity firm specializing in middle-market buyouts, restructurings, and turnaround investments in distressed companies. Founded in 2000 by Wilbur Ross, the firm gained prominence for its strategic interventions in heavy industries such as steel, coal, and textiles. While primarily a generalist industrial investor, the firm has a significant history of involvement in the healthcare and life sciences sectors through the acquisition of distressed pharmaceutical assets and medical device manufacturers. Notable activities include providing debtor-in-possession financing for Aralez Pharmaceuticals and holding stakes in companies like Claris Lifesciences and Nipro Corporation. Since 2006, the firm has operated as a specialized investment division within Invesco Ltd.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WL Ross & Co..